Author

Andrew C. Williams

University of Washington

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alison Donnelly AxtmaniD· 1 shared Arunima SikdariD· 1 shared Dongxue WangiD· 1 shared Frances M. BashoreiD· 1 shared Gregory A. CaryiD· 1 shared Gregory W. CarteriD· 1 shared Haian FuiD· 1 shared Jake GockleyiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Alison Donnelly AxtmanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Characterization of covalent inhibitors that disrupt the interaction between the tandem SH2 domains of SYK and FCER1G phospho-ITAM

Frances M. Bashore, Vittorio L. Katis, Yuhong Du, Arunima Sikdar, Dongxue Wang, William J. Bradshaw, Karolina A. Rygiel, Tina M. Leisner, Rod Chalk, Swati Mishra, Andrew C. Williams, O. Gileadi, Paul E. Brennan, Jesse C. Wiley, Jake Gockley, , Alison Donnelly Axtman

The paper identifies two covalent inhibitors that disrupt the interaction between SYK's tandem SH2 domains and FCER1G phospho-ITAM, potentially beneficial for Alzheimer's disease therapy.

PLoS ONE · Feb 15, 2024Peer-reviewedNeuroscience